全球合成生物學和生物製造市場（2026-2036）

全球合成生物學和生物製造市場是現代生物經濟中最具變革性的產業之一，它融合了先進生物技術、計算生物學和永續製造。該市場將工程原理應用於生物學，從而實現生物系統的設計、建造和優化，用於工業化生產化學品、材料、燃料、藥品和食品配料。

隨著生物基生產方法在幾乎所有工業領域的應用加速，合成生物學市場預計到2036年將呈現顯著成長。越來越多的公司尋求可持續的替代方案，以取代石油化工工藝和傳統製造方式。工業酵素是整個生物製造業的重要組成部分，預計將以8.6%的複合年增長率成長，這主要得益於其在洗滌劑、食品加工、紡織品、生物燃料和藥品生產等領域的應用不斷擴展。

三大核心技術平台正在推動市場轉型。精準發酵利用基因工程改造的微生物，以空前的效率生產特定的蛋白質、酵素和代謝物，其應用領域涵蓋替代蛋白、乳製品配料和特殊化學品。無細胞系統提供了一種繞過傳統細胞限制的全新方法，可實現 40-70% 的能源效率提升、更短的反應時間和更純淨的產品特性。人工智慧設計的酵素利用機器學習和計算生物學，將酵素的開發時間從數年縮短至數週，從而能夠快速優化用於工業製程的生物催化劑。

該市場涵蓋六大主要應用領域。生物製藥仍然是最大的細分市場，包括單株抗體、重組蛋白、疫苗、細胞和基因療法以及生物相似藥。工業酵素的應用範圍廣泛，包括洗滌劑、食品加工、紡織、造紙和紙漿、皮革加工以及生物燃料生產，其中碳水化合物降解酶約佔 38% 的市場佔有率。生物燃料包括生物乙醇、生質柴油、沼氣、永續航空燃料以及新興的生物氫生產。生物塑膠和生物材料包括聚乳酸 (PLA)、聚羥基脂肪酸酯 (PHA)、生物基聚乙烯以及蜘蛛絲蛋白和菌絲體複合材料等新型材料。生物化學品涵蓋有機酸、胺基酸、維生素、生物表面活性劑和生物基單體。生物農業涵蓋用於永續農業的生物農藥、生物肥料和生物刺激劑。 多種因素正在推動市場成長。監管壓力和永續發展要求日益傾向於生物基工藝，而碳定價機制正在提升生物生產的經濟競爭力。 CRISPR 基因組編輯、DNA 合成和高通量篩選等技術的進步顯著縮短了研發時間和降低了成本。人工智慧與生物設計的融合正在加速新型酵素和代謝途徑的發現與最佳化。企業永續發展措施和消費者對環保產品的需求正在推動整個供應鏈的採用。

競爭格局的特點是充滿活力的生態系統，既有成熟的生物技術和化學公司，也有新創公司和平台技術供應商。超過700家公司活躍於價值鏈的各個環節，涵蓋平台技術供應商、菌株設計專家、生產規模製造商和終端產品開發商。在創投、策略性企業投資和政府資助項目的支持下，投資活動依然強勁，為持續創新和規模化發展提供了動力。

本報告深入探討了全球合成生物學和生物製造市場，並提供了市場規模預測、技術路線圖、區域市場收入和預測，以及超過900家公司的概況。

簡介中包含的公司

否則

目次

第 1 章 エグゼkurekkusamari

• 報告概述
• 電影バイオマュfakuchiharinguの美國と表目
• 主要搜尋結果とハイライト
• 世界世界市場電影と成動電影（2026年～2036年）
• 市場のセグロングションシームシーム
• 科技電視：複合生物學、工業玻璃、白色生物技術
• 下載動向と感動旅行最術
• 這個自然と這個可以動向
• 科技之路地圖（2026年～2036年） 分析
• 生技 English

第2章 バイオマュfaァkuchiharingunointorodashon

• gössé biologischen・バイオマュfuァクチャringuno定義
• gốtsọ biểnhạiềọọọọọọọọọọọ
• 電視應生歌機正視的電視
• 電影用バイオマュfuァクチャringunoムロングロックト
• 劇情片 電視劇劇情簡介：
• 世界教育上海手機性
• 這個性了上的恩恵と電影したしたしたします

第三章技術技術

• バイオマュfakuchiharingu 流程概述
• 生產系統
• 白素発酒
• 無結果電視
• AI英語玻絡、設計生物學
• バイオマュfaァクチャringu向生電影工業
• 支援技術
• 上流電視
• 下流電視
• 替代原料to可以tohaますます
• 手機の見通しととした

第4章生業用維水と生體面平台

• 摘要與分類
• 技術與材料分析
• 製作方法
• 市場分析

• バイオショーショー·法發
• 農業·食品
• バイオケミカル
• 生物塑料
• ロイターディード
• 環境
• 耶財

第 6 章世界世界市場透過と思了

概述
• 市場：技術平台其他
• 市場：電影其他
• 市場：電影內容其他
• 市場：地地別
• 投資と這個安全の分析

第7章市場分析

• SWOT分析
• ポーターのfeibufeisu分析 分析
• 公開情勢と市場ママkku
• 技術成熟度電平等級（TRL）
• 情勢
• 電影の最作
• 政府的支持與政策

第8章上海社計（上海915筆視劇情）

第 9 章參考文

'The global synthetic biology and biomanufacturing market' represents one of the most transformative sectors in the modern bioeconomy, positioned at the intersection of advanced biotechnology, computational biology, and sustainable manufacturing. This market encompasses the application of engineering principles to biology, enabling the design, construction, and optimization of biological systems for industrial production of chemicals, materials, fuels, pharmaceuticals, and food ingredients.

The synthetic biology market is projected to experience exceptional growth by 2036 due to the accelerating adoption of bio-based production methods across virtually every industrial sector as companies seek sustainable alternatives to petrochemical processes and traditional manufacturing. The industrial enzymes segment, a critical component of the broader biomanufacturing landscape, is forecast to grow at a CAGR of 8.6%, driven by expanding applications in detergents, food processing, textiles, biofuels, and pharmaceutical manufacturing.

Three core technology platforms are driving market transformation. Precision fermentation utilizes genetically engineered microorganisms to produce specific proteins, enzymes, and metabolites with unprecedented efficiency, finding applications in alternative proteins, dairy ingredients, and specialty chemicals. Cell-free systems represent an emerging approach that bypasses traditional cellular constraints, offering 40-70% energy efficiency improvements, faster reaction times, and cleaner product profiles. AI-designed enzymes leverage machine learning and computational biology to accelerate enzyme development from years to weeks, enabling rapid optimization of biocatalysts for industrial processes.

The market spans six primary application sectors. Biopharmaceuticals remain the largest segment, encompassing monoclonal antibodies, recombinant proteins, vaccines, cell and gene therapies, and biosimilars. Industrial enzymes serve diverse applications including detergents, food processing, textiles, paper and pulp, leather processing, and biofuel production, with carbohydrases commanding approximately 38% market share. Biofuels encompass bioethanol, biodiesel, biogas, sustainable aviation fuel, and emerging biohydrogen production. Bioplastics and biomaterials include polylactic acid (PLA), polyhydroxyalkanoates (PHAs), bio-based polyethylene, and novel materials such as spider silk proteins and mycelium composites. Biochemicals cover organic acids, amino acids, vitamins, biosurfactants, and bio-based monomers. Bio-agritech addresses biopesticides, biofertilizers, and biostimulants for sustainable agriculture.

Multiple factors are propelling market growth. Regulatory pressure and sustainability mandates increasingly favor bio-based processes, while carbon pricing mechanisms improve the economic competitiveness of biological production. Technological advances in CRISPR genome editing, DNA synthesis, and high-throughput screening have dramatically reduced development timelines and costs. The convergence of artificial intelligence with biological design is accelerating the discovery and optimization of novel enzymes and metabolic pathways. Corporate sustainability commitments and consumer demand for environmentally responsible products are driving adoption across supply chains.

The competitive landscape features established biotechnology and chemical companies alongside a vibrant ecosystem of startups and platform technology providers. Over 700 companies actively participate across the value chain, from foundational technology providers and strain engineering specialists to production-scale manufacturers and end-product developers. Investment activity remains robust, with venture capital, corporate strategic investment, and government funding programs supporting continued innovation and scale-up.

This report takes an integrated approach recognizing that synthetic biology, industrial enzymes, and white biotechnology are interconnected segments of the broader industrial biomanufacturing market rather than distinct separate markets. Three revolutionary technology platforms are driving unprecedented market growth: precision fermentation enables production of proteins, enzymes, and specialty ingredients through engineered microorganisms; cell-free systems offer 40-70% energy efficiency improvements with faster reaction times and cleaner product profiles; and AI-designed enzymes leverage machine learning and computational biology to reduce enzyme development timelines from years to weeks.

The biomanufacturing revolution is enabling sustainable alternatives to petrochemical processes across multiple end-use markets. Biopharmaceuticals lead market value with monoclonal antibodies, recombinant proteins, vaccines, cell and gene therapies, and biosimilars. Industrial enzymes serve detergents, food processing, textiles, paper and pulp, leather, biofuels, animal feed, and pharmaceutical applications, with carbohydrases commanding 38% market share. Biofuels encompass bioethanol, biodiesel, biogas, sustainable aviation fuel, biohydrogen, and biomethanol production. Bioplastics and biomaterials include PLA, PHAs, bio-PE, bio-PET, PBS, PEF, and novel materials such as spider silk proteins, mycelium composites, and bacterial cellulose. Biochemicals cover organic acids, amino acids, vitamins, alcohols, biosurfactants, flavors and fragrances, and bio-based monomers. Bio-agritech addresses biopesticides, biofertilizers, and biostimulants for sustainable agriculture.

Market growth is propelled by regulatory mandates favoring bio-based processes, corporate sustainability commitments, carbon pricing mechanisms, and technological breakthroughs in CRISPR genome editing, DNA synthesis, and high-throughput screening. The convergence of artificial intelligence with biological design is accelerating discovery and optimization of novel enzymes and metabolic pathways. Government initiatives including the US Bioeconomy Strategy, EU Green Deal, and China's biotechnology policies provide substantial funding and regulatory support.

Report Contents Include:

• Executive summary with key findings, market size projections, and technology roadmap 2026-2036
• Technology analysis covering precision fermentation, cell-free systems, AI-designed enzymes, cell factories, genome editing, metabolic engineering, and bioprocess development
• Industrial enzymes and biocatalysts analysis by type (carbohydrases, proteases, lipases, amylases, oxidoreductases) and application
• End-use market analysis for biopharmaceuticals, agriculture/food, biochemicals, bioplastics, biofuels, environmental applications, and consumer goods
• Global market revenues and forecasts by technology platform, application sector, product type, and region
• Industry analysis including SWOT, value chain analysis, technology readiness levels, and regulatory landscape
• 900+ company profiles with comprehensive coverage across all market segments
• 348 data tables and 158 figures with market forecasts through 2036

Companies Profiled include:

and more.....

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

• 1.1. Report Overview and Scope
  • 1.1.1. Report Scope and Coverage
  • 1.1.2. Analytical Framework
  • 1.1.3. Geographic Coverage
• 1.2. Definition and Scope of Industrial Biomanufacturing
  • 1.2.1. Defining Industrial Biomanufacturing
  • 1.2.2. Scope of Technologies Covered
  • 1.2.3. Market Boundaries
  • 1.2.4. Relationship to Adjacent Markets
• 1.3. Key Findings and Highlights
  • 1.3.1. Technology Advancement Has Dramatically Reduced Barriers
  • 1.3.2. Commercial Validation Continues to Expand
  • 1.3.3. Investment Momentum Remains Strong
  • 1.3.4. Sustainability Is Becoming a Competitive Advantage
  • 1.3.5. Scale-Up Remains the Critical Challenge
• 1.4. Global Market Size and Growth Projections 2026-2036
  • 1.4.1. Market Size Evolution
  • 1.4.2. Growth Drivers
  • 1.4.3. Growth Rate Analysis by Segment
• 1.5. Market Segmentation Overview
  • 1.5.1. Segmentation by Technology Platform
  • 1.5.2. Segmentation by Application Sector
  • 1.5.3. Segmentation by Product Type
  • 1.5.4. Segmentation by Geography
• 1.6. Technology Convergence: Synthetic Biology, Industrial Enzymes, and White Biotechnology
  • 1.6.1. Historical Separation of Markets
  • 1.6.2. Drivers of Convergence
  • 1.6.3. Implications for Market Analysis
  • 1.6.4. Competitive Implications
• 1.7. Major Trends and Growth Drivers
  • 1.7.1. Sustainability Mandates
  • 1.7.2. Technology Cost Reduction
  • 1.7.3. Scale-Up Success
  • 1.7.4. AI/ML Integration
  • 1.7.5. Consumer Demand
• 1.8. Investment Landscape and Funding Trends
  • 1.8.1. Venture Capital Investment
  • 1.8.2. Corporate Strategic Investment
  • 1.8.3. Government Funding
  • 1.8.4. Investment Focus Areas
• 1.9. Technology Roadmap 2026-2036
  • 1.9.1. Near-Term Developments (2026-2028)
  • 1.9.2. Mid-Term Developments (2029-2032)
  • 1.9.3. Long-Term Vision (2033-2036)
• 1.10. Value Chain Analysis
  • 1.10.1. Feedstock Supply
  • 1.10.2. Technology and Intellectual Property
  • 1.10.3. Production and Manufacturing
  • 1.10.4. Distribution and End-Users
  • 1.10.5. Value Capture Analysis
• 1.11. Colours of Biotechnology
  • 1.11.1. Red Biotechnology (Medical/Pharmaceutical)
  • 1.11.2. White Biotechnology (Industrial)
  • 1.11.3. Green Biotechnology (Agricultural)
  • 1.11.4. Blue Biotechnology (Marine)
  • 1.11.5. Yellow Biotechnology (Food)
  • 1.11.6. Grey Biotechnology (Environmental)
  • 1.11.7. Gold Biotechnology (Bioinformatics/Computational)
  • 1.11.8. Report Focus

2. INTRODUCTION TO BIOMANUFACTURING

• 2.1. Definition of Synthetic Biology and Biomanufacturing
  • 2.1.1. Foundational Principles of Synthetic Biology
  • 2.1.2. Genetic Circuits and Metabolic Engineering
  • 2.1.3. Definition of Biomanufacturing
• 2.2. Difference Between Synthetic Biology and Genetic Engineering
  • 2.2.1. Traditional Genetic Engineering
  • 2.2.2. Synthetic Biology Approach
  • 2.2.3. Practical Implications
• 2.3. Historical Evolution of Industrial Biotechnology
  • 2.3.1. Traditional Fermentation Era (Pre-1970s)
  • 2.3.2. Recombinant DNA Era (1970s-1990s)
  • 2.3.3. Genomics and Systems Biology Era (1990s-2000s)
  • 2.3.4. Synthetic Biology Era (2000s-Present)
  • 2.3.5. AI Integration Era (2020s-Future)
• 2.4. Key Components of Industrial Biomanufacturing
  • 2.4.1. Strain Engineering
  • 2.4.2. Fermentation and Cell Culture
  • 2.4.3. Downstream Processing
  • 2.4.4. Process Analytical Technology (PAT)
  • 2.4.5. Quality Control and Assurance
• 2.5. Comparison with Conventional Chemical Processes
  • 2.5.1. Selectivity and Stereochemistry
  • 2.5.2. Complex Molecule Synthesis
  • 2.5.3. Reaction Conditions
  • 2.5.4. Feedstock and Sustainability
  • 2.5.5. Limitations of Biomanufacturing
  • 2.5.6. Hybrid Processes
• 2.6. Importance in the Global Economy
  • 2.6.1. Role in Healthcare and Pharmaceuticals
  • 2.6.2. Biopharmaceutical Market Scale
  • 2.6.3. Manufacturing Complexity
    • 2.6.3.1. Emerging Modalities
  • 2.6.4. Impact on Industrial Sustainability
    • 2.6.4.1. Carbon Footprint Reduction
    • 2.6.4.2. Resource Efficiency
    • 2.6.4.3. Corporate and Regulatory Drivers
  • 2.6.5. Food Security Applications
    • 2.6.5.1. Alternative Proteins
    • 2.6.5.2. Agricultural Biotechnology
    • 2.6.5.3. Food Ingredients
  • 2.6.6. Circular Economy Integration
    • 2.6.6.1. Waste Valorization
    • 2.6.6.2. Enzymatic Recycling
    • 2.6.6.3. Biodegradable Materials
• 2.7. Sustainability Benefits and Environmental Impact
  • 2.7.1. Life Cycle Assessment Framework
  • 2.7.2. Emissions
  • 2.7.3. Energy Consumption
  • 2.7.4. Water Use
  • 2.7.5. Land Use
  • 2.7.6. Toxicity and Environmental Release

3. TECHNOLOGY ANALYSIS

• 3.1. Biomanufacturing Processes Overview
  • 3.1.1. Batch Production
  • 3.1.2. Fed-Batch Production
  • 3.1.3. Continuous Production
  • 3.1.4. Perfusion Culture
• 3.2. Production Systems
  • 3.2.1. Bacterial Systems
  • 3.2.2. Yeast Systems
  • 3.2.3. Mammalian Cell Culture
  • 3.2.4. Other Production Systems
• 3.3. Precision Fermentation
  • 3.3.1. Technology Overview and Principles
  • 3.3.2. Production Methods and Scale-Up
  • 3.3.3. Commercial Applications
    • 3.3.3.1. Alternative Proteins
    • 3.3.3.2. Specialty Ingredients
  • 3.3.4. Market Outlook
• 3.4. Cell-Free Systems
  • 3.4.1. Technology Overview
  • 3.4.2. Advantages Over Cell-Based Systems
  • 3.4.3. Commercial Applications
  • 3.4.4. Market Outlook
• 3.5. AI-Designed Enzymes and Computational Biology
  • 3.5.1. Computational Enzyme Design
  • 3.5.2. Machine Learning Integration
  • 3.5.3. Traditional vs AI-Driven Development
• 3.6. Cell Factories for Biomanufacturing
  • 3.6.1. Established Chassis Organisms
  • 3.6.2. Emerging and Specialized Organisms
• 3.7. Supporting Technologies
  • 3.7.1. DNA Synthesis and Gene Assembly
  • 3.7.2. Genome Editing Technologies
  • 3.7.3. Metabolic Engineering
  • 3.7.4. Protein Engineering
• 3.8. Upstream Processing
  • 3.8.1. Bioreactor Systems
  • 3.8.2. Process Analytical Technology (PAT)
• 3.9. Downstream Processing
  • 3.9.1. Primary Recovery
  • 3.9.2. Purification Technologies
  • 3.9.3. Formulation
• 3.10. Alternative Feedstocks and Sustainability
  • 3.10.1. Traditional Feedstocks
  • 3.10.2. C1 Feedstocks
  • 3.10.3. Lignocellulosic Biomass
  • 3.10.4. Waste Stream Valorization
  • 3.10.5. Carbon Capture Integration
• 3.11. Technology Outlook and Implications

4. INDUSTRIAL ENZYMES AND BIOCATALYSTS

• 4.1. Overview and Classification
  • 4.1.1. Bio-Manufactured Enzymes
  • 4.1.2. Enzyme Types and Functions
    • 4.1.2.1. Carbohydrases
    • 4.1.2.2. Proteases
    • 4.1.2.3. Lipases
    • 4.1.2.4. Amylases
    • 4.1.2.5. Oxidoreductases
• 4.2. Technology and Materials Analysis
  • 4.2.1. Detergent Enzymes
  • 4.2.2. Food Processing Enzymes
  • 4.2.3. Textile Processing Enzymes
  • 4.2.4. Paper and Pulp Enzymes
  • 4.2.5. Leather Processing Enzymes
  • 4.2.6. Biofuel Production Enzymes
    • 4.2.6.1. Cellulases for Lignocellulosic Bioethanol
    • 4.2.6.2. Hemicellulases and Synergistic Cocktails
    • 4.2.6.3. Thermostable and Extremophilic Enzymes
  • 4.2.7. Animal Feed Enzymes
  • 4.2.8. Pharmaceutical and Diagnostic Enzymes
  • 4.2.9. Waste Management and Bioremediation Enzymes
    • 4.2.9.1. Enzymes for Plastics Recycling
    • 4.2.9.2. Enzymatic Depolymerization
  • 4.2.10. Agriculture and Crop Improvement Enzymes
  • 4.2.11. Enzymes for Decarbonization and CO2 Utilization
    • 4.2.11.1. Carbonic Anhydrase in CO2 Capture
    • 4.2.11.2. Formate Dehydrogenase Pathways
• 4.3. Production Methods
  • 4.3.1. Extraction from Natural Sources
  • 4.3.2. Microbial Fermentation Production
  • 4.3.3. Genetically Engineered Organisms
  • 4.3.4. Cell-Free Systems Production
  • 4.3.5. Immobilized Enzyme Systems
• 4.4. Market Analysis
  • 4.4.1. Key Players and Competitive Landscape
  • 4.4.2. Market Growth Drivers and Trends
  • 4.4.3. Technology Challenges and Opportunities
  • 4.4.4. Economic Competitiveness Analysis
  • 4.4.5. Pricing Dynamics
  • 4.4.6. Regulatory Landscape
  • 4.4.7. Value Chain Analysis
  • 4.4.8. Risks and Opportunities

5. END-USE MARKETS AND APPLICATIONS

• 5.1. Biopharmaceuticals and Healthcare
  • 5.1.1. Monoclonal Antibodies (mAbs)
  • 5.1.2. Recombinant Proteins
  • 5.1.3. Vaccines
  • 5.1.4. Cell and Gene Therapies
  • 5.1.5. Blood Factors
  • 5.1.6. Nucleic Acid Therapeutics
  • 5.1.7. Peptide Therapeutics
  • 5.1.8. Biosimilars and Biobetters
  • 5.1.9. Nanobodies and Antibody Fragments
  • 5.1.10. Tissue Engineering Products
  • 5.1.11. Drug Discovery and Personalized Medicine
  • 5.1.12. Biopharmaceuticals Regulations
  • 5.1.13. Market Analysis and Outlook
    • 5.1.13.1. Value Chain
    • 5.1.13.2. Market Growth Drivers and Trends
    • 5.1.13.3. Key players
• 5.2. Agriculture and Food
  • 5.2.1. Alternative Proteins
    • 5.2.1.1. Precision Fermentation for Food Proteins
    • 5.2.1.2. Cultivated Meat
    • 5.2.1.3. Microbial Protein (Single-Cell Protein)
  • 5.2.2. Food Ingredients
    • 5.2.2.1. Natural Flavours and Fragrances
    • 5.2.2.2. Natural Sweeteners
    • 5.2.2.3. Food Colourants and Other Ingredients
  • 5.2.3. Agricultural Biologicals
    • 5.2.3.1. Biofertilizers
    • 5.2.3.2. Biopesticides
    • 5.2.3.3. Biostimulants
  • 5.2.4. Feed Additives and Animal Nutrition
  • 5.2.5. Crop Improvement and Gene Editing
  • 5.2.6. Market Analysis and Outlook
    • 5.2.6.1. Key players
• 5.3. Biochemicals
  • 5.3.1. Organic Acids
    • 5.3.1.1. Lactic Acid
    • 5.3.1.2. Succinic Acid
    • 5.3.1.3. Citric Acid
    • 5.3.1.4. Other Organic Acids
  • 5.3.2. Platform Chemicals and Diols
    • 5.3.2.1. 1,3-Propanediol (1,3-PDO)
    • 5.3.2.2. 1,4-Butanediol (BDO)
  • 5.3.3. Alcohols and Solvents
    • 5.3.3.1. Bioethanol
    • 5.3.3.2. Isobutanol
    • 5.3.3.3. n-Butanol
  • 5.3.4. Amino Acids
    • 5.3.4.1. L-Glutamate
    • 5.3.4.2. L-Lysine
    • 5.3.4.3. Other Amino Acids
  • 5.3.5. Biosurfactants
    • 5.3.5.1. Rhamnolipids
    • 5.3.5.2. Sophorolipids
    • 5.3.5.3. Mannosylerythritol Lipids (MELs)
  • 5.3.6. Vitamins and Nutraceuticals
  • 5.3.7. Specialty Chemicals and Polymer Intermediates
    • 5.3.7.1. Polybutylene Succinate (PBS) Intermediates
    • 5.3.7.2. Polyethylene Furanoate (PEF) Intermediates
  • 5.3.8. Gas Fermentation and C1 Chemicals
  • 5.3.9. Market Analysis and Outlook
    • 5.3.9.1. Key players
• 5.4. Bioplastics
  • 5.4.1. Polylactic Acid (PLA)
  • 5.4.2. Polyhydroxyalkanoates (PHAs)
  • 5.4.3. Bio-based Polyethylene (Bio-PE)
  • 5.4.4. Bio-based PET
  • 5.4.5. Polybutylene Succinate (PBS)
  • 5.4.6. Starch-based Plastics
  • 5.4.7. PBAT (Polybutylene Adipate Terephthalate)
  • 5.4.8. Polyethylene Furanoate (PEF)
  • 5.4.9. Bio-based Polyamides (Nylons)
  • 5.4.10. Cellulose-Based Bioplastics.
  • 5.4.11. Emerging Bioplastic Technologies
    • 5.4.11.1. Mycelium-based Materials
    • 5.4.11.2. Algae-based Plastics
  • 5.4.12. Bioplastic Blends and Compounds
  • 5.4.13. Bioplastics End-of-Life Options
  • 5.4.14. Market Analysis and Outlook
    • 5.4.14.1. Market Growth Drivers and Trends
    • 5.4.14.2. Value Chain
    • 5.4.14.3. Addressable Market Size
    • 5.4.14.4. Risks and Opportunities in Bioplastics
  • 5.4.15. Global Revenues for Bioplastics by Type 2020-2036
    • 5.4.15.1. Bioplastics Regulations
    • 5.4.15.2. Key players
• 5.5. Biofuels
  • 5.5.1. Biofuel Feedstocks
  • 5.5.2. Bioethanol
    • 5.5.2.1. First-Generation Bioethanol
    • 5.5.2.2. Second-Generation (Cellulosic) Bioethanol
  • 5.5.3. Biodiesel
  • 5.5.4. Renewable Diesel (HVO)
  • 5.5.5. Sustainable Aviation Fuel (SAF)
  • 5.5.6. Gas Fermentation
  • 5.5.7. Biogas and Biomethane
    • 5.5.7.1. Anaerobic Digestion
    • 5.5.7.2. Biomass Gasification
    • 5.5.7.3. Power-to-Methane
  • 5.5.8. Biochar and Bio-oil
  • 5.5.9. Biobutanol
  • 5.5.10. Algal Biofuels
  • 5.5.11. Future Trends in Biofuels
  • 5.5.12. Market Analysis and Outlook
    • 5.5.12.1. Market Growth Drivers
    • 5.5.12.2. Biofuels Regulations
    • 5.5.12.3. Value Chain
    • 5.5.12.4. Key players
• 5.6. Environmental Applications
  • 5.6.1. Market Overview
  • 5.6.2. Bioremediation Technologies
  • 5.6.3. Wastewater Treatment
  • 5.6.4. Plastic Biodegradation
  • 5.6.5. Carbon Capture and Utilization
  • 5.6.6. Air Biotreatment
  • 5.6.7. Value Chain Analysis
  • 5.6.8. Regulatory Landscape
  • 5.6.9. Key Players
  • 5.6.10. Market Trends and Drivers
  • 5.6.11. Future Outlook
• 5.7. Consumer Goods
  • 5.7.1. Market Overview
  • 5.7.2. Personal Care and Cosmetics
  • 5.7.3. Home Care and Cleaning Products
  • 5.7.4. Fragrances and Flavours
  • 5.7.5. Textiles and Fashion
  • 5.7.6. Value Chain Analysis
  • 5.7.7. Regulations and Certifications
  • 5.7.8. Key Players
  • 5.7.9. Market Drivers and Trends
  • 5.7.10. Future Outlook

6. GLOBAL MARKET REVENUES AND FORECASTS

• 6.1. Industrial Biomanufacturing Market Overview
  • 6.1.1. Total Addressable Market 2026-2036
  • 6.1.2. Market Integration and Overlaps
  • 6.1.3. Technology Convergence Drivers
    • 6.1.3.1. Cost Reduction Drivers
    • 6.1.3.2. Precision Engineering Capabilities
    • 6.1.3.3. AI Integration
• 6.2. Market by Technology Platform
  • 6.2.1. Synthetic Biology Technologies
  • 6.2.2. Precision Fermentation
  • 6.2.3. Cell-Free Systems
  • 6.2.4. AI and Computational Biology Platforms
  • 6.2.5. Traditional Fermentation Systems
  • 6.2.6. Technology Platform Comparison
• 6.3. Market by Application Sector
  • 6.3.1. Biopharmaceuticals
    • 6.3.1.1. Market Overview and Global Revenues 2020-2036
    • 6.3.1.2. Market Segmentation by Product Type
    • 6.3.1.3. Regional Market Analysis
  • 6.3.2. Industrial Enzymes and Biocatalysts
    • 6.3.2.1. Market Overview and Global Revenues 2020-2036
    • 6.3.2.2. Market Segmentation by Enzyme Type
    • 6.3.2.3. Market Segmentation by Source
  • 6.3.3. Biofuels
    • 6.3.3.1. Market Overview and Global Revenues 2020-2036
    • 6.3.3.2. Market Segmentation by Application
    • 6.3.3.3. Regional Market Analysis
  • 6.3.4. Bioplastics and Biomaterials
    • 6.3.4.1. Market Overview and Global Revenues 2020-2036
    • 6.3.4.2. Material Type Analysis
    • 6.3.4.3. Application Market Analysis
    • 6.3.4.4. Regional Market Analysis
  • 6.3.5. Biochemicals
    • 6.3.5.1. Market Overview and Global Revenues 2020-2036
    • 6.3.5.2. Application Market Analysis
    • 6.3.5.3. Regional Market Analysis
  • 6.3.6. Bio-Agritech
    • 6.3.6.1. Market Overview and Global Revenues 2020-2036
    • 6.3.6.2. Regional Market Analysis
• 6.4. Market by Product Type
  • 6.4.1. Synthetic Biology Products
• 6.5. Market by Region
  • 6.5.1. North America
  • 6.5.2. Europe
  • 6.5.3. Asia-Pacific
  • 6.5.4. Rest of World
• 6.6. Investment and Funding Analysis
  • 6.6.1. Venture Capital Trends
  • 6.6.2. Corporate Investment
  • 6.6.3. Government Funding Programs

7. MARKET ANALYSIS

• 7.1. SWOT Analysis
  • 7.1.1. Industrial Biomanufacturing SWOT
  • 7.1.2. Precision Fermentation SWOT
  • 7.1.3. Cell-Free Systems SWOT
  • 7.1.4. AI-Designed Enzymes SWOT
• 7.2. Porter's Five Forces Analysis
• 7.3. Value Chain Analysis
  • 7.3.1. Feedstock Suppliers
    • 7.3.1.1. Primary Feedstock Categories
    • 7.3.1.2. Production and Manufacturing
  • 7.3.2. Distribution and End-Users
    • 7.3.2.1. Distribution Models
    • 7.3.2.2. End-User Segments
  • 7.3.3. Economic Viability Factors
    • 7.3.3.1. Cost Structure Components
  • 7.3.4. Scale-Up Cost Analysis
    • 7.3.4.1. Scale-Up Economics
• 7.4. Competitive Landscape and Market Map
  • 7.4.1. Market Map by Category
  • 7.4.2. Competitive Positioning
    • 7.4.2.1. Positioning Dimensions
  • 7.4.3. Strategic Groups Analysis
• 7.5. Technology Readiness Levels (TRL)
  • 7.5.1. Biopharmaceuticals TRL
  • 7.5.2. Industrial Enzymes TRL
  • 7.5.3. Biofuels TRL
  • 7.5.4. Bioplastics TRL
  • 7.5.5. Biochemicals TRL
• 7.6. Regulatory Landscape
  • 7.6.1. United States Regulations
  • 7.6.2. European Union Regulations
  • 7.6.3. Asia-Pacific Regulations
  • 7.6.4. International Standards
    • 7.6.4.1. Key International Bodies
  • 7.6.5. Biosafety and Biosecurity
• 7.7. Industry Challenges
  • 7.7.1. Production Cost Challenges
  • 7.7.2. Scale-Up Barriers
  • 7.7.3. Public Perception
  • 7.7.4. Technical Challenges
  • 7.7.5. Feedstock Price Impacts
• 7.8. Government Support and Policy
  • 7.8.1. US Bioeconomy Initiatives
  • 7.8.2. EU Green Deal and Bioeconomy Strategy
  • 7.8.3. China Biotechnology Policy
  • 7.8.4. Carbon Tax Implications

8. COMPANY PROFILES (915 company profiles)

9. REFERENCES

List of Tables

• Table 1. Scope of Industrial Biomanufacturing Technologies
• Table 2. DNA Synthesis Cost Decline 2000-2024
• Table 3. Advanced Technologies in Biomanufacturing Applications
• Table 4. Key Market Metrics and Growth Projections 2026-2036
• Table 5. Global Synthetic Biology Market by Technology Segment 2026-2036 (USD Billion)
• Table 6. Global Synthetic Biology Market Growth 2020-2036
• Table 7. Market Segmentation by Technology Platform 2026 vs 2036
• Table 8. Market Segmentation by Application Sector 2026-2036
• Table 9. Global Market Share by Region 2026 vs 2036
• Table 10. AI and Robotics Applications in Biomanufacturing
• Table 11. Technology Convergence Examples Across Traditional Market Boundaries
• Table 12. Regulatory Drivers for Bio-Based Products by Region
• Table 13. Technology Cost Reduction Trends 2000-2036
• Table 14. AI/ML Applications in Biomanufacturing Systems
• Table 15. Major Trends and Growth Drivers Summary
• Table 16. Venture Capital Investment in Synthetic Biology 2015-2024
• Table 17. Major Synthetic Biology Funding Rounds 2023-2024]
• Table 18. Government Biotechnology Funding by Region
• Table 19. Investment Focus Areas and Key Companies]
• Table 20. Feedstock Types and Characteristics
• Table 21.Production Cost Breakdown by Product Category
• Table 22. Value Chain Position and Value Capture
• Table 23. Colours of Biotechnology Classification
• Table 24. White Biotechnology Fermentation Processes
• Table 25. Blue Biotechnology Feedstock Characteristics and Applications
• Table 26. Genetic Circuit Components and Functions
• Table 27. Comparison of Genetic Engineering and Synthetic Biology Approaches
• Table 28.Biomanufacturing Revolutions and Representative Products
• Table 29. Key Milestones in Recombinant DNA Era
• Table 30. Industrial Biotechnology Eras and Characteristics
• Table 31. Key Components of Industrial Biomanufacturing
• Table 32. Strain Engineering Approaches and Tools
• Table 33. Types of Cell Culture Systems
• Table 34. Factors Affecting Cell Culture Performance
• Table 35. Advances in Fermentation Technology
• Table 36.Types of Purification Methods in Downstream Processing
• Table 37. Downstream Processing Unit Operations
• Table 38. Factors Affecting Purification Performance
• Table 39. Downstream Processing Technology Improvements
• Table 40. Types of Quality Control Tests in Biomanufacturing
• Table 41. Common Formulation Methods Used in Biomanufacturing
• Table 42. Comparison of Biomanufacturing and Chemical Synthesis
• Table 43. Complexity Comparison-Chemical vs Biological Synthesis Routes
• Table 44. Environmental Comparison-Selected Bio-Based vs Petrochemical Products]
• Table 45. Synthesis Route Comparison by Product Category
• Table 46. Advances in Formulation Technology
• Table 47. Hybrid Biotechnological-Chemical Process Applications
• Table 48. Biopharmaceutical Market by Category
• Table 49. Sustainability Drivers and Bio-Based Responses
• Table 50. Alternative Protein Market Projections
• Table 51. Waste Valorization Pathways in Biomanufacturing
• Table 52. Circular Economy Integration Examples
• Table 53. GHG Emissions Comparison-Bio-Based vs Conventional Products
• Table 54. Water Use in Biomanufacturing vs Chemical Processes
• Table 55. Environmental Impact Summary-Bio-Based Production Advantages
• Table 56. Process Mode Selection Decision Framework
• Table 57. Batch Production Characteristics
• Table 58.Continuous vs Batch Biomanufacturing Comparison
• Table 59. Production Mode Comparison Summary
• Table 60. Production System Comparison
• Table 61. Factors Affecting Scale-up Performance in Biomanufacturing
• Table 62. Scale-up Strategies in Biomanufacturing
• Table 63. Precision Fermentation Strain Development Pipeline
• Table 64. Precision Fermentation Companies and Products
• Table 65. Precision Fermentation Market by Application 2024-2036 (USD Billion)
• Table 66. Cell-Free Systems Market by Application 2024-2036 (USD Billion)
• Table 67. Machine Learning Applications in Biomanufacturing
• Table 68. Development Approach Comparison
• Table 69. Major Microbial Cell Factories Used in Industrial Biomanufacturing
• Table 70. Organism Categories and Production Capabilities
• Table 71. E. coli Characteristics for Biomanufacturing Applications
• Table 72. Chassis Organism Comparison
• Table 73. C. glutamicum Production Capabilities and Characteristics
• Table 74. B. subtilis Production Systems and Applications
• Table 75. S. cerevisiae Capabilities and Industrial Applications
• Table 76. Y. lipolytica Production Capabilities and Process Parameters
• Table 77. Non-Model Organisms and Specialized Applications
• Table 78. DNA Synthesis Technologies and Capabilities
• Table 79. CRISPR-Cas9 Applications in Biomanufacturing
• Table 80. Protein Engineering Strategies and Applications
• Table 81. Computer-Aided Design Tools in Biotechnology
• Table 82. C1 Feedstock Utilization Pathways and Characteristics
• Table 83. C2 Feedstock Processing and Applications
• Table 84. Lignocellulosic Feedstock Characteristics
• Table 85. Lignocellulosic Biomass Processing Technologies
• Table 86. Automation Applications in Biotechnology
• Table 87. Types of Industrial Enzymes
• Table 88. EC Classification of Industrial Enzymes
• Table 89. Industrial Enzyme Types and Applications
• Table 90.Types of Detergent Enzymes
• Table 91. Types of Food Processing Enzymes
• Table 92. Food Processing Enzyme Applications
• Table 93. Types of Textile Processing Enzymes
• Table 94. Types of Paper and Pulp Processing Enzymes
• Table 95. Types of Leather Processing Enzymes
• Table 96. Biofuel Enzyme Requirements and Performance
• Table 97. Types of Biofuel Production Enzymes
• Table 98. Lignocellulosic Enzyme Systems and Performance
• Table 99. Cellulase Component Functions and Characteristics
• Table 100. Hemicellulase Systems and Substrate Specificity
• Table 101. Thermostable Enzyme Sources and Characteristics
• Table 102. Types of Animal Feed Enzymes
• Table 103. Types of Pharmaceutical and Diagnostic Enzymes
• Table 104. Types of Waste Management and Bioremediation Enzymes
• Table 105. Enzymes for Plastics Recycling Applications
• Table 106. Enzymatic Plastic Recycling Development Status
• Table 107. Challenges in Enzymatic Depolymerization
• Table 108. Types of Agriculture and Crop Improvement Enzymes
• Table 109. Comparison of Enzyme Types
• Table 110. Enzymes for Decarbonization and CO2 Utilization
• Table 111. Carbonic Anhydrase Applications in CO2 Capture
• Table 112. Formate Dehydrogenase Systems for CO2 Conversion
• Table 113. Immobilized Enzyme Systems and Applications
• Table 114. Market Growth Drivers and Trends in Industrial Enzymes
• Table 115. Technology Challenges and Opportunities for Industrial Enzymes
• Table 116. Industrial Enzymes Regulations
• Table 117. Value Chain: Industrial Enzymes
• Table 118. Industrial Enzyme Market Forecast by Application 2024-2036 (USD Billion)
• Table 119. Types of Biopharmaceuticals
• Table 120. Types of biopharmaceuticals
• Table 121. Technology Readiness Level (TRL): Biopharmaceuticals
• Table 122. Types of Monoclonal Antibodies
• Table 123. Host organisms commonly used in biopharmaceutical manufacturing
• Table 124. Cell Line Development Platform Comparison
• Table 125. Advances in Purification Technology
• Table 126. Key players in monoclonal antibodies
• Table 127. Types of Recombinant Proteins
• Table 128. Types of biopharma vaccines
• Table 129. Companies involved in synthetic biology for vaccine production
• Table 130. Types of Cell and Gene Therapies
• Table 131. Companies involved in synthetic biology for gene therapy and regenerative medicine
• Table 132. Types of Blood Factors
• Table 133. Types of Nucleic Acid Therapeutics
• Table 134. Types of Peptide Therapeutics
• Table 135. Types of Biosimilars and Biobetters
• Table 136. Types of Nanobodies and Antibody Fragments
• Table 137. Types of Tissue Engineering Products
• Table 138. Companies involved in synthetic biology for gene therapy and regenerative medicine
• Table 139. Risks and Opportunities in biopharmaceuticals
• Table 140. Biopharmaceuticals Regulations
• Table 141. Addressable market size for biopharmaceuticals
• Table 142. Global revenues for biopharmaceuticals, by applications market (2020-2036), billions USD
• Table 143. Global revenues for biopharmaceuticals, by regional market (2020-2036), billions USD
• Table 144. Risks and Opportunities in Biopharmaceuticals
• Table 145. Biopharmaceutical Manufacturing Value Chain: Detailed Overview
• Table 146. Market Growth Drivers and Trends in Biopharmaceuticals
• Table 147. Key players in biopharmaceuticals
• Table 148. Risks and Opportunities in Agriculture and Food Biotechnology
• Table 149. Alternative protein production approaches
• Table 150. Companies developing precision fermentation-derived food proteins
• Table 151. Companies developing cultivated meat
• Table 152. Companies developing microbial biomass proteins
• Table 153. Biofertilizer companies and products
• Table 154. Main types of biopesticides
• Table 155. Biopesticides companies and products
• Table 156. Biostimulants companies and products
• Table 157. Agriculture and food biotechnology market summary
• Table 158. Key players in agriculture and food biotechnology
• Table 159. Technology Readiness Levels for biochemicals
• Table 160. Types of biochemicals produced through biomanufacturing
• Table 161. Lactic acid applications and market segments
• Table 162. Leading lactic acid and PLA producers
• Table 163. Biobased feedstock sources for succinic acid production
• Table 164. Applications of succinic acid
• Table 165. Applications of bio-based 1,3-Propanediol
• Table 166. Applications of bio-based 1,4-Butanediol
• Table 167. Key molecules for biobased synthetic polymers
• Table 168. Applications of bio-based isobutanol
• Table 169. Major amino acid production volumes and applications
• Table 170. Types of biosurfactants
• Table 171. Rhamnolipid production and application characteristics
• Table 172. Sophorolipid types and application properties
• Table 173. Applications of biosurfactants
• Table 174. PBS market analysis
• Table 175. Biochemicals market summary by segment
• Table 176. Key players in biochemicals
• Table 177. Risks and Opportunities in Biochemicals
• Table 178. Technology Readiness Levels for bioplastics
• Table 179. Classification of Bioplastics
• Table 180. Risks and Opportunities in Bioplastics
• Table 181. Types of bioplastics
• Table 182. Properties of Bioplastics Compared to Conventional Plastics
• Table 183. Bioplastics and bioplastic precursors synthesized via biotechnology processes
• Table 184. PLA Properties and Grades
• Table 185. PLA market analysis-manufacture, advantages, disadvantages, and applications
• Table 186. PLA producers and production capacities
• Table 187. Types of PHAs and properties
• Table 188. Commercially available PHAs
• Table 189. PHA producers and capacities
• Table 190. PBS market analysis-manufacture, advantages, disadvantages, and applications
• Table 191. PBS and PBAT Properties
• Table 192. Leading PBS producers and production capacities
• Table 193. Starch-Based Bioplastics
• Table 194. Bio-Polyamides (Bio-PA)
• Table 195. Cellulose-Based Bioplastics
• Table 196. Emerging Bioplastics
• Table 197. Types of polymer blends with bio-based components
• Table 198. Bioplastics Processing Technologies
• Table 199. Bioplastics End-of-Life Options
• Table 200. Market Growth Drivers and Trends in Bioplastics
• Table 201. Value Chain: Bioplastics
• Table 202. Addressable Market Size for Bioplastics
• Table 203. Risks and Opportunities in Bioplastics
• Table 204. Global Revenues for Bioplastics by Type 2020-2036
• Table 205. Global Revenues for Bioplastics by Applications Market 2020-2036
• Table 206. Bioplastics Regulations
• Table 207. Key players in bioplastics
• Table 208. Types of Biofuel by Generation
• Table 209. Technology Readiness Levels for biofuels
• Table 210. Comparison of biofuels
• Table 211. Comparison of biofuels and e-fuels to fossil fuels and electricity
• Table 212. Classification of biomass feedstock
• Table 213. Biorefinery Feedstocks
• Table 214. Types of biofuel by generation
• Table 215. Feedstock Conversion Pathways
• Table 216. Biobased feedstock sources for ethanol
• Table 217. Lignocellulosic ethanol plants and capacities
• Table 218. Comparison of Pulping and Biorefinery Lignins
• Table 219. Commercial and Pre-Commercial Biorefinery Lignin Production Facilities
• Table 220.Operating and Planned Lignocellulosic Biorefineries
• Table 221. Conventional biofuel types
• Table 222. Biodiesel by Generation
• Table 223. Biodiesel Production Techniques
• Table 224. Biofuel Production Cost from the Biomass Pyrolysis Process
• Table 225. Properties of Vegetable Oils in Comparison to Diesel
• Table 226. Global Biodiesel Consumption 2010-2036 (Million litres/year)
• Table 227. Main producers of HVO and capacities
• Table 228. Renewable diesel price ranges by region
• Table 229. Example Commercial Development of BtL Processes
• Table 230. Pilot or Demo Projects for Biomass to Liquid (BtL) Processes
• Table 231. Global Renewable Diesel Consumption 2010-2036 (Million litres/year)
• Table 232. Renewable Diesel Price Ranges
• Table 233. Advantages and disadvantages of bio-aviation fuel
• Table 234. Advantages and Disadvantages of Bio-Aviation Fuel
• Table 235. Production Pathways for Bio-Aviation Fuel
• Table 236. Current and Announced Bio-Aviation Fuel Facilities and Capacities
• Table 237. Global Bio-Jet Fuel Consumption 2019-2036 (Million litres/year)
• Table 238. Comparison of biogas, biomethane, and natural gas
• Table 239. Biogas Feedstocks
• Table 240. Existing and Planned Bio-LNG Production Plants
• Table 241. Methods for Capturing Carbon Dioxide from Biogas
• Table 242. Comparison of Different Bio-H2 Production Pathways
• Table 243. Markets and Applications for Biohydrogen
• Table 244. Summary of Applications of Biochar in Energy
• Table 245. Typical Composition and Physicochemical Properties for Bio-Oils
• Table 246. Properties and Characteristics of Pyrolysis Liquids Derived from Biomass
• Table 247. Main Techniques Used to Upgrade Bio-Oil into Higher-Quality Fuels
• Table 248. Markets and Applications for Bio-Oil
• Table 249. Bio-Oil Producers
• Table 250. Properties of Microalgae and Macroalgae
• Table 251. Yield of Algae and Other Biodiesel Crops
• Table 252. Algae-Derived Biofuel Producers
• Table 253. Addressable Market Size for Biofuels
• Table 254. Risks and Opportunities in Biofuels
• Table 255. Global Revenues for Biofuels by Type 2020-2036
• Table 256. Global Revenues for Biofuels by Applications Market 2020-2036
• Table 257. Global Revenues for Biofuels by Regional Market 2020-2036
• Table 258. Market Growth Drivers and Trends in Biofuels
• Table 259. Biofuels Regulations
• Table 260. Value Chain: Biofuels
• Table 261. Key players in biofuels
• Table 262. Environmental Biotechnology Market Overview
• Table 263. Bioremediation Technology Applications and Capabilities
• Table 264. Applications of Synthetic Biology in Bioremediation
• Table 265. Biological Wastewater Treatment Technologies
• Table 266. Enzymes and Microbial Products for Wastewater Treatment
• Table 267. Enzymatic Plastic Degradation Technologies
• Table 268. Commercial and Development-Stage Plastic Biodegradation Initiatives
• Table 269. Carbon Capture Integration Pathways for Biomanufacturing: Overview
• Table 270. Economic Analysis of Carbon Capture Integration Pathways
• Table 271. Biological Carbon Capture Technologies
• Table 272. Key Companies in Biological Carbon Capture
• Table 273. Air Biotreatment Technologies and Applications
• Table 274. Air Biotreatment Applications by Industry
• Table 275. Environmental Biotechnology Value Chain
• Table 276. Regulatory Framework for Environmental Biotechnology
• Table 277. Key Companies in Environmental Biotechnology
• Table 278. Environmental Biotechnology Market Drivers and Trends
• Table 279. Environmental Biotechnology Market Forecast (2024-2036)
• Table 280. Consumer Goods Biotechnology Market Overview
• Table 281. Biotechnology Applications in Personal Care and Cosmetics
• Table 282. Key Personal Care Biotechnology Ingredients
• Table 283. Enzymes in Home Care Products
• Table 284. Sustainable Ingredients for Home Care Products
• Table 285. Home Care Enzyme Market by Application
• Table 286. Biotechnology-Derived Fragrances and Flavours
• Table 287. Major F&F Companies and Biotechnology Investments
• Table 288. Biotechnology Applications in Textiles
• Table 289. Bio-based Fiber and Material Producers
• Table 290. Consumer Goods Biotechnology Value Chain
• Table 291. Regulatory Framework for Consumer Goods Biotechnology
• Table 292. Key Companies in Consumer Goods Biotechnology
• Table 293. Consumer Goods Biotechnology Market Drivers
• Table 294. Consumer Goods Biotechnology Market Forecast (2024-2036)
• Table 295. Total Addressable Market Summary by Sector (Billion USD)
• Table 296. Technology-Application Matrix
• Table 297. Technology Convergence Drivers and Timeline
• Table 298. Global Revenues for Synthetic Biology by Technology, 2020-2036 (Billion USD)
• Table 299. Precision Fermentation Products and Applications
• Table 300. Cell-Free vs Cell-Based Systems Comparison
• Table 301. AI-Driven Fermentation Platform Companies
• Table 302. Types of Fermentation Processes
• Table 303. Key Fermentation Parameter Comparison
• Table 304. Technology Platform Comparison Matrix
• Table 305. Global Revenues for Biopharmaceuticals by Application (2020-2036), Billions USD
• Table 306. Biopharmaceutical Market by Product Category
• Table 307. Global Revenues for Biopharmaceuticals by Region (2020-2036), Billions USD
• Table 308. Global Revenues for Industrial Enzymes (Billion USD)
• Table 309. Market Segmentation by Type of Industrial Enzymes 2023-2036 (Billion USD)
• Table 310. Market Segmentation by Source of Industrial Enzymes 2023-2036 (Billion USD)
• Table 311. Global Revenues for Biofuels by Type (2020-2036), Billions USD
• Table 312. Global Revenues for Biofuels by Application (2020-2036), Billions USD
• Table 313. Global Revenues for Biofuels by Region (2020-2036), Billions USD
• Table 314. Global Revenues for Bioplastics by Type (2020-2036), Billions USD
• Table 315. Types of PHAs and Properties
• Table 316. Global Revenues for Bioplastics by Application (2020-2036), Billions USD
• Table 317. Global Revenues for Bioplastics by Region (2020-2036), Billions USD
• Table 318. Global Revenues for Biochemicals by Type (2020-2036), Billions USD
• Table 319. Global Revenues for Biochemicals by Application (2020-2036), Billions USD
• Table 320. Global Revenues for Biochemicals by Region (2020-2036), Billions USD
• Table 321. Global Revenues for Bio-Agritech by Application (2020-2036), Billions USD
• Table 322. Global Revenues for Bio-Agritech by Region (2020-2036), Billions USD
• Table 323. Global Revenues for Synthetic Biology by Product Type, 2020-2036 (Billion USD)
• Table 324. Global Revenues for Synthetic Biology by Region, 2020-2036 (Billion USD)
• Table 325. White Biotechnology Revenues by Region, 2020-2035 (Billion USD)
• Table 326. Selected Major Investments in Synthetic Biology
• Table 327. Porter's Five Forces Analysis: Synthetic Biology and Biomanufacturing
• Table 328. Feedstock Supplier Landscape and Characteristics
• Table 329.Production Scale Economics
• Table 330. End-User Segment Analysis
• Table 331. Economic Viability Assessment Framework
• Table 332. Scale-Up Cost Impact Analysis
• Table 333. Market Map: Synthetic Biology and Biomanufacturing
• Table 334.Competitive Positioning Matrix
• Table 335.U.S. Regulatory Framework Summary
• Table 336.EU Regulatory Framework Summary
• Table 337.Asia-Pacific Regulatory Framework Comparison
• Table 338. International Standards and Harmonization
• Table 339. Biosafety and Biosecurity Framework
• Table 340. Production Cost Breakdown by Product Type
• Table 341. Scale-Up Factors and Mitigation Strategies
• Table 342. Technical Challenge Assessment
• Table 343. Feedstock Price Impact Analysis
• Table 344. US Government Biotechnology Funding
• Table 345. EU Bioeconomy Support Mechanisms
• Table 346. Carbon Price Impact on Production Economics
• Table 347. Lactips plastic pellets
• Table 348. Oji Holdings CNF products

List of Figures

• Figure 1. Key Market Metrics and Growth Projections 2026-2036
• Figure 2. Technology Readiness and Commercial Maturity by Application Sector
• Figure 3. Global Synthetic Biology Market by Technology Segment 2026-2036 (USD Billion)
• Figure 4. Global Synthetic Biology Market Growth 2020-2036
• Figure 5. Technology Convergence in Industrial Biomanufacturing
• Figure 6. AI/ML Applications Across Biomanufacturing Value Chain
• Figure 7. Technology Roadmap 2026-2028: Near-Term Developments
• Figure 8. Technology Roadmap 2029-2032: Mid-Term Developments
• Figure 9. Technology Roadmap 2033-2036: Long-Term Vision
• Figure 10. Industrial Biomanufacturing Value Chain Overview
• Figure 11.Biomanufacturing Production System Overview
• Figure 12. Evolution from Genetic Engineering to Synthetic Biology
• Figure 13. Timeline of Industrial Biotechnology Development
• Figure 14. Biopharmaceutical Manufacturing Value Chain
• Figure 15. Alternative Protein Production Pathways
• Figure 16. Life Cycle Assessment Framework for Bio-Based Products
• Figure 17. Precision Fermentation Market by Application 2024-2036 (USD Billion)
• Figure 18. Cell-Free Systems Market by Application 2024-2036 (USD Billion)
• Figure 19. Carbon Capture Integration Pathways for Biomanufacturing
• Figure 20. Industrial Enzyme Market Forecast by Application 2024-2036 (USD Billion)
• Figure 21. Global revenues for biopharmaceuticals, by applications market (2020-2036), billions USD
• Figure 22. Total Addressable Market Summary by Sector (Billion USD)
• Figure 23. Global Revenues for Synthetic Biology by Technology, 2020-2036 (Billion USD)
• Figure 24. Global Revenues for Biopharmaceuticals by Application (2020-2036), Billions USD
• Figure 25. Global Revenues for Industrial Enzymes (Billion USD)
• Figure 26. Market Segmentation by Type of Industrial Enzymes 2023-2036 (Billion USD)
• Figure 27. Global Revenues for Biofuels by Type (2020-2036), Billions USD
• Figure 28. Global Revenues for Biofuels by Application (2020-2036), Billions USD
• Figure 29. Global Revenues for Bioplastics by Type (2020-2036), Billions USD
• Figure 30. Global Revenues for Bioplastics by Application (2020-2036), Billions USD
• Figure 31. Global Revenues for Biochemicals by Type (2020-2036), Billions USD
• Figure 32. Global Revenues for Biochemicals by Application (2020-2036), Billions USD
• Figure 33. Global Revenues for Bio-Agritech by Application (2020-2036), Billions USD
• Figure 34. SWOT Analysis: Industrial Biomanufacturing
• Figure 35. SWOT Analysis: Precision Fermentation
• Figure 36. SWOT Analysis: Cell-Free Systems
• Figure 37. SWOT Analysis: AI-Designed Enzymes
• Figure 38. Technology Readiness Level: Biopharmaceuticals
• Figure 39. Technology Readiness Level: Industrial Enzymes
• Figure 40. Technology Readiness Level: Biofuels
• Figure 41. Technology Readiness Level: Bioplastics
• Figure 42. Technology Readiness Level: Biochemicals.#
• Figure 43. Pluumo
• Figure 44. Algiknit yarn
• Figure 45. Jelly-like seaweed-based nanocellulose hydrogel
• Figure 46. ANDRITZ Lignin Recovery process
• Figure 47. Anpoly cellulose nanofiber hydrogel
• Figure 48. MEDICELLU(TM)
• Figure 49. Asahi Kasei CNF fabric sheet
• Figure 50. Properties of Asahi Kasei cellulose nanofiber nonwoven fabric
• Figure 51. CNF nonwoven fabric
• Figure 52. Roof frame made of natural fiber
• Figure 53. Beyond Leather Materials product
• Figure 54. BIOLO e-commerce mailer bag made from PHA
• Figure 55. Reusable and recyclable foodservice cups, lids, and straws from Joinease Hong Kong Ltd., made with plant-based NuPlastiQ BioPolymer from BioLogiQ, Inc
• Figure 56. Fiber-based screw cap
• Figure 57: Celluforce production process
• Figure 58: NCCTM Process
• Figure 59: CNC produced at Tech Futures' pilot plant; cloudy suspension (1 wt.%), gel-like (10 wt.%), flake-like crystals, and very fine powder. Product advantages include:
• Figure 60. formicobio(TM) technology
• Figure 61. nanoforest-S
• Figure 62. nanoforest-PDP
• Figure 63. nanoforest-MB
• Figure 64. sunliquid-R production process
• Figure 65. sunliquid-R production process
• Figure 66. CuanSave film
• Figure 67. Celish
• Figure 68. Trunk lid incorporating CNF
• Figure 69. ELLEX products
• Figure 70. CNF-reinforced PP compounds
• Figure 71. Kirekira! toilet wipes
• Figure 72. Color CNF
• Figure 73. Rheocrysta spray
• Figure 74. DKS CNF products
• Figure 75. Domsjo process
• Figure 76. Mushroom leather
• Figure 77. CNF based on citrus peel
• Figure 78. Citrus cellulose nanofiber
• Figure 79. Filler Bank CNC products
• Figure 80. Fibers on kapok tree and after processing
• Figure 81. TMP-Bio Process
• Figure 82. Flow chart of the lignocellulose biorefinery pilot plant in Leuna
• Figure 83. Water-repellent cellulose
• Figure 84. Cellulose Nanofiber (CNF) composite with polyethylene (PE)
• Figure 85. PHA production process
• Figure 86. CNF products from Furukawa Electric
• Figure 87. AVAPTM process
• Figure 88. GreenPower+(TM) process
• Figure 89. Cutlery samples (spoon, knife, fork) made of nano cellulose and biodegradable plastic composite materials
• Figure 90. Non-aqueous CNF dispersion "Senaf" (Photo shows 5% of plasticizer)
• Figure 91. CNF gel
• Figure 92. Block nanocellulose material
• Figure 93. CNF products developed by Hokuetsu
• Figure 94. Marine leather products
• Figure 95. Inner Mettle Milk products
• Figure 96. Kami Shoji CNF products
• Figure 97. Dual Graft System
• Figure 98. Engine cover utilizing Kao CNF composite resins
• Figure 99. Acrylic resin blended with modified CNF (fluid) and its molded product (transparent film), and image obtained with AFM (CNF 10wt% blended)
• Figure 100. Kel Labs yarn
• Figure 101. 0.3% aqueous dispersion of sulfated esterified CNF and dried transparent film (front side)
• Figure 102. Light Bio Bioluminescent plants
• Figure 103. Lignin gel
• Figure 104. BioFlex process
• Figure 105. Nike Algae Ink graphic tee
• Figure 106. LX Process
• Figure 107. Made of Air's HexChar panels
• Figure 108. TransLeather
• Figure 109. Chitin nanofiber product
• Figure 110. Marusumi Paper cellulose nanofiber products
• Figure 111. FibriMa cellulose nanofiber powder
• Figure 112. METNIN(TM) Lignin refining technology
• Figure 113. IPA synthesis method
• Figure 114. MOGU-Wave panels
• Figure 115. CNF slurries
• Figure 116. Range of CNF products
• Figure 117. Reishi
• Figure 118. Compostable water pod
• Figure 119. Leather made from leaves
• Figure 120. Nike shoe with beLEAF(TM)
• Figure 121. CNF clear sheets
• Figure 122. Oji Holdings CNF polycarbonate product
• Figure 123. Enfinity cellulosic ethanol technology process
• Figure 124. Precision Photosynthesis(TM) technology
• Figure 125. Fabric consisting of 70 per cent wool and 30 per cent Qmilk
• Figure 126. XCNF
• Figure 127: Plantrose process
• Figure 128. LOVR hemp leather
• Figure 129. CNF insulation flat plates
• Figure 130. Hansa lignin
• Figure 131. Manufacturing process for STARCEL
• Figure 132. Manufacturing process for STARCEL
• Figure 133. 3D printed cellulose shoe
• Figure 134. Lyocell process
• Figure 135. North Face Spiber Moon Parka
• Figure 136. PANGAIA LAB NXT GEN Hoodie
• Figure 137. Spider silk production
• Figure 138. Stora Enso lignin battery materials
• Figure 139. 2 wt.% CNF suspension
• Figure 140. BiNFi-s Dry Powder
• Figure 141. BiNFi-s Dry Powder and Propylene (PP) Complex Pellet
• Figure 142. Silk nanofiber (right) and cocoon of raw material
• Figure 143. Sulapac cosmetics containers
• Figure 144. Sulzer equipment for PLA polymerization processing
• Figure 145. Solid Novolac Type lignin modified phenolic resins
• Figure 146. Teijin bioplastic film for door handles
• Figure 147. Corbion FDCA production process
• Figure 148. Comparison of weight reduction effect using CNF
• Figure 149. CNF resin products
• Figure 150. UPM biorefinery process
• Figure 151. Vegea production process
• Figure 152. The Proesa-R Process
• Figure 153. Goldilocks process and applications
• Figure 154. Visolis' Hybrid Bio-Thermocatalytic Process
• Figure 155. HefCel-coated wood (left) and untreated wood (right) after 30 seconds flame test
• Figure 156. Worn Again products
• Figure 157. XtalPi's automated and robot-run workstations
• Figure 158. Zelfo Technology GmbH CNF production process